ArticleDiabetes & vascular disease research
Skin autofluorescence may be a biomarker associated suboptimal glycemic control in pregnant women with gestational diabetes mellitus.
Article in Diabetes & vascular disease research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BackgroundAdvanced glycation end products (AGEs) can be measured non-invasively through skin autofluorescence (SAF). Studies on SAF in gestational diabetes mellitus (GDM) remain limited. This study aims to evaluate SAF in Tunisian pregnant women with GDM and its association with the requirement for insulin therapy.MethodsA cross sectional study was conducted of 242 pregnant women who visited at the Monastir-Tunisia Center for Maternity. Screening for GDM was performed using the OGTT. 200 pregnant women were included in the study with and without GDM. We measured SAF using the AGE reader Mu device and the age-adjusted SAF-z score was calculated.ResultsHigher SAF levels and SAF-z scores were observed in pregnant women with GDM compared to healthy controls (2.1 ± 0.5 AU vs 1.9 ± 0.4 AU
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.